[The acute electrophysiological effects of amiodarone on normal and hypertrophied rat myocytes]. 2006

Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
Department of Cardiology, First Affiliated Hospital of Soochow University, Suzhou 215006, China.

OBJECTIVE The aim of the present study was to investigate the acute action of amiodarone (AM) on the inward currents I(Na), I(Ca-L) and outward currents I(k), I(k1), I(to) in hypertrophied and normal rat ventricular myocytes. METHODS The pressure overload hypertrophy rat model was established by partial ligation of ascending aorta for 4 weeks. Ventricular myocytes were exposed to 0.01, 0.1, 1, 10 and 50 micromol/L AM and whole cell patch clamp technique was used to study the acute effects of AM on the inward currents I(Na), I(Ca-L) and outward currents I(k), I(k1), I(to). RESULTS (1) Compared with the normal ventricular myocytes, the current density of I(k), I(ks), I(to) and I(k1) were all decreased in hypertrophied myocytes, but I(Na) and I(Ca-L) remained unchanged. (2) I(Ca-L) was blocked by 59.0% +/- 4.4% in normal myocytes but only blocked by 16.7% +/- 8.0% in hypertrophied myocytes after 50 micromol/L AM application; IC(50) of I(Na) were 9.2 micromol/L and 5.9 micromol/L in normal and in hypertrophied myocytes, respectively; I(to) was blocked by 55.9% +/- 5.5% in normal myocytes and 23.0% +/- 2.8% in hypertrophied myocytes after 50 micromol/L AM application. I(k1) was not affected by AM in both normal and hypertrophied myocytes; I(ks) was blocked by 21.6% +/- 5.6% in normal myocytes and 42.7% +/- 9.2% in hypertrophied myocytes after 10 micromol/L AM application. CONCLUSIONS Our results show that the sensitivity of hypertrophied myocytes to AM on I(Na), I(ks) were higher than that of normal myocytes, while the sensitivity on I(Ca-L), I(k1), I(to) were lower than that of normal myocytes favoring the use of AM on hypertrophied myocardium for antiarrhythmic therapy.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018408 Patch-Clamp Techniques An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used. Patch Clamp Technique,Patch-Clamp Technic,Patch-Clamp Technique,Voltage-Clamp Technic,Voltage-Clamp Technique,Voltage-Clamp Techniques,Whole-Cell Recording,Patch-Clamp Technics,Voltage-Clamp Technics,Clamp Technique, Patch,Clamp Techniques, Patch,Patch Clamp Technic,Patch Clamp Technics,Patch Clamp Techniques,Recording, Whole-Cell,Recordings, Whole-Cell,Technic, Patch-Clamp,Technic, Voltage-Clamp,Technics, Patch-Clamp,Technics, Voltage-Clamp,Technique, Patch Clamp,Technique, Patch-Clamp,Technique, Voltage-Clamp,Techniques, Patch Clamp,Techniques, Patch-Clamp,Techniques, Voltage-Clamp,Voltage Clamp Technic,Voltage Clamp Technics,Voltage Clamp Technique,Voltage Clamp Techniques,Whole Cell Recording,Whole-Cell Recordings
D020257 Ventricular Remodeling The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle. Cardiac Remodeling, Ventricular,Left Ventricular Remodeling,Myocardial Remodeling, Ventricular,Left Ventricle Remodeling,Ventricle Remodeling,Cardiac Remodelings, Ventricular,Left Ventricle Remodelings,Left Ventricular Remodelings,Myocardial Remodelings, Ventricular,Remodeling, Left Ventricle,Remodeling, Left Ventricular,Remodeling, Ventricle,Remodeling, Ventricular,Remodeling, Ventricular Cardiac,Remodeling, Ventricular Myocardial,Remodelings, Left Ventricle,Remodelings, Left Ventricular,Remodelings, Ventricle,Remodelings, Ventricular,Remodelings, Ventricular Cardiac,Remodelings, Ventricular Myocardial,Ventricle Remodeling, Left,Ventricle Remodelings,Ventricle Remodelings, Left,Ventricular Cardiac Remodeling,Ventricular Cardiac Remodelings,Ventricular Myocardial Remodeling,Ventricular Myocardial Remodelings,Ventricular Remodeling, Left,Ventricular Remodelings,Ventricular Remodelings, Left
D032383 Myocytes, Cardiac Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC). Cardiomyocytes,Muscle Cells, Cardiac,Muscle Cells, Heart,Cardiac Muscle Cell,Cardiac Muscle Cells,Cardiac Myocyte,Cardiac Myocytes,Cardiomyocyte,Cell, Cardiac Muscle,Cell, Heart Muscle,Cells, Cardiac Muscle,Cells, Heart Muscle,Heart Muscle Cell,Heart Muscle Cells,Muscle Cell, Cardiac,Muscle Cell, Heart,Myocyte, Cardiac

Related Publications

Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
June 1993, Journal of hypertension,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
April 2001, Archives of physiology and biochemistry,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
May 1989, The American journal of physiology,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
January 1990, The American journal of cardiovascular pathology,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
June 1995, The Journal of clinical investigation,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
December 1988, The American journal of physiology,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
January 1989, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
November 2010, European journal of pharmacology,
Lin Zhou, and Bin Jiang, and Hong-xia Li, and Tan Chen, and Xu-jie Cheng, and Wen-ping Jiang
October 1994, Cardiovascular research,
Copied contents to your clipboard!